Renal Cancer - Results from #2920

Modeling clear cell renal cell carcinoma and therapeutic implications. March 11, 2020

Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma. March 10, 2020

The Therapeutic Landscape of Renal Cell Carcinoma: From the Dark Age to the Golden Age. March 10, 2020

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma. March 10, 2020

Potential New Therapeutic Approaches for Renal Cell Carcinoma. March 9, 2020

Patient-reported outcomes from the phase 3 randomized IMmotion151 trial: atezolizumab + bevacizumab vs sunitinib in treatment-naive metastatic renal cell carcinoma. March 9, 2020

TBK1 Activation by VHL Loss in Renal Cell Carcinoma: A Novel HIF-Independent Vulnerability. March 9, 2020

Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients. March 6, 2020

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma. March 6, 2020

Metatarsal metastasis from clear cell renal cell carcinoma: a case report and literature review. March 6, 2020

New Preoperative Nomogram Using the Centrality Index to Predict High Nuclear Grade Clear Cell Renal Carcinoma. March 5, 2020

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression. March 5, 2020

Expression profile of H3K4 demethylases with their clinical and pathological correlation in patients with clear cell renal cell carcinoma. March 5, 2020

Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3. March 4, 2020

The Prognostic Value of Body Fat Components in Metastasis Renal Cell Carcinoma Patients Treated with TKIs. March 4, 2020

Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis. March 3, 2020

Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts. March 3, 2020

Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma. March 3, 2020

Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis. March 2, 2020

Significant Contribution of DNA Repair Human 8-Oxoguanine DNA N-Glycosylase 1 Genotypes to Renal Cell Carcinoma. March 2, 2020

Page 147 of 456